<?xml version='1.0' encoding='utf-8'?>
<document id="2109992"><sentence text="[Aspects of antiepileptic drug therapy in children]." /><sentence text="During the past 10 years, better results in the treatment of epilepsy have been obtained through the application of pharmacokinetic data to drug therapy of epilepsy" /><sentence text=" However, pediatric drug therapy is complicated by the continuous change in body weight and body composition with the growth and development, especially during infancy" /><sentence text=" Younger children require a higher dose per kilogram of body weight than older children in order to achieve comparable plasma concentrations" /><sentence text=" Plasma levels and seizure control were investigated in a prospective randomized study when phenytoin, carbamazepine (CBZ) or sodium valproate (VPA) was given as a single drug to pediatric patients with several types of epileptic seizures"><entity charOffset="92-101" id="DDI-PubMed.2109992.s5.e0" text="phenytoin" /><entity charOffset="103-116" id="DDI-PubMed.2109992.s5.e1" text="carbamazepine" /><entity charOffset="118-121" id="DDI-PubMed.2109992.s5.e2" text="CBZ" /><entity charOffset="126-142" id="DDI-PubMed.2109992.s5.e3" text="sodium valproate" /><entity charOffset="144-147" id="DDI-PubMed.2109992.s5.e4" text="VPA" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e0" e2="DDI-PubMed.2109992.s5.e0" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e0" e2="DDI-PubMed.2109992.s5.e1" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e0" e2="DDI-PubMed.2109992.s5.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e0" e2="DDI-PubMed.2109992.s5.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e0" e2="DDI-PubMed.2109992.s5.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e1" e2="DDI-PubMed.2109992.s5.e1" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e1" e2="DDI-PubMed.2109992.s5.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e1" e2="DDI-PubMed.2109992.s5.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e1" e2="DDI-PubMed.2109992.s5.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e2" e2="DDI-PubMed.2109992.s5.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e2" e2="DDI-PubMed.2109992.s5.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e2" e2="DDI-PubMed.2109992.s5.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e3" e2="DDI-PubMed.2109992.s5.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s5.e3" e2="DDI-PubMed.2109992.s5.e4" /></sentence><sentence text=" Studies on newly referred, previously untreated children suggest that both partial and generalized tonic-clonic seizures can be prevented by each of the three drugs" /><sentence text=" No significant differences in clinical efficacy were found among the three drugs, when optimum plasma concentration ranges were maintained with blood level monitoring" /><sentence text=" Clonazepam (CZP) may be effective in partial seizures"><entity charOffset="1-11" id="DDI-PubMed.2109992.s8.e0" text="Clonazepam" /><entity charOffset="13-16" id="DDI-PubMed.2109992.s8.e1" text="CZP" /><pair ddi="false" e1="DDI-PubMed.2109992.s8.e0" e2="DDI-PubMed.2109992.s8.e0" /><pair ddi="false" e1="DDI-PubMed.2109992.s8.e0" e2="DDI-PubMed.2109992.s8.e1" /></sentence><sentence text=" However, as a wide range of plasma levels was associated with complete freedom from seizures, it was not possible to define a therapeutic range for CZP"><entity charOffset="149-151" id="DDI-PubMed.2109992.s9.e0" text="CZP" /></sentence><sentence text=" Any patient who receives multiple-drug therapy is at risk to develop a drug-drug interaction" /><sentence text=" Simultaneous administration of VPA was associated with a raised plasma level of carbamazepine-10,11-epoxide (CBZ-E), a major metabolite of CBZ, relative to the CBZ dose, whereas the plasma CBZ level remained unaltered"><entity charOffset="32-35" id="DDI-PubMed.2109992.s11.e0" text="VPA" /><entity charOffset="81-108" id="DDI-PubMed.2109992.s11.e1" text="carbamazepine-10,11-epoxide" /><entity charOffset="110-115" id="DDI-PubMed.2109992.s11.e2" text="CBZ-E" /><entity charOffset="140-144" id="DDI-PubMed.2109992.s11.e3" text="CBZ" /><entity charOffset="161-165" id="DDI-PubMed.2109992.s11.e4" text="CBZ" /><entity charOffset="190-194" id="DDI-PubMed.2109992.s11.e5" text="CBZ" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e0" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e1" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e0" e2="DDI-PubMed.2109992.s11.e5" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e1" e2="DDI-PubMed.2109992.s11.e1" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e1" e2="DDI-PubMed.2109992.s11.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e1" e2="DDI-PubMed.2109992.s11.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e1" e2="DDI-PubMed.2109992.s11.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e1" e2="DDI-PubMed.2109992.s11.e5" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e2" e2="DDI-PubMed.2109992.s11.e2" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e2" e2="DDI-PubMed.2109992.s11.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e2" e2="DDI-PubMed.2109992.s11.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e2" e2="DDI-PubMed.2109992.s11.e5" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e3" e2="DDI-PubMed.2109992.s11.e3" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e3" e2="DDI-PubMed.2109992.s11.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e3" e2="DDI-PubMed.2109992.s11.e5" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e4" e2="DDI-PubMed.2109992.s11.e4" /><pair ddi="false" e1="DDI-PubMed.2109992.s11.e4" e2="DDI-PubMed.2109992.s11.e5" /></sentence><sentence text=" High plasma concentration of CBZ-E may be responsible for side effects in some patients"><entity charOffset="30-32" id="DDI-PubMed.2109992.s12.e0" text="CBZ" /></sentence><sentence text=" Drug-protein binding interactions are another source of side effects" /><sentence text="(ABSTRACT TRUNCATED AT 250 WORDS)" /></document>